Previous data derived from several in vitro studies increasingly pointed to the critical role of FOXP3 as a tumor suppressor, including repressing tumor cell proliferation, promoting apoptosis and reducing cell invasion in at least breast, prostate and ovarian carcinoma models [10, 12, 32]. Here, FOXP3 is linked to ovarian carcinoma.